Simulations Plus (SLP)
Simulations Plus Revenues: 2.789M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SLP Revenues Rankings
| Overall | 4th percentile | 4232 of 4431 |
| Sector | 2nd percentile | 823 of 848 in Technology |
| Industry | 3rd percentile | 56 of 58 in Business Software & Services |
SLP Revenues Range, Past 5 Years
| Minimum | 1.84M | Aug 2008 |
| Maximum | 3.439M | May 2011 |
| Average | 2.517M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these SLP related companies
SLP News
Simulations Plus (SLP) Releases MedChem Studio 3.0 and MedChem Designer 2.0
May 03, 8:00AM Business Wire
May 03, 8:00AM Business Wire
$SLP forms bullish "Ascending Continuation Triangle" chart pattern. http://stks.co/3dfy
about 30 days ago by RecogniaEvents
about 30 days ago by RecogniaEvents
$SLP http://stks.co/3TY9 SLP Regression. $SLP post 2008 recovery regression
about 39 days ago by GnomishMath
about 39 days ago by GnomishMath
Simulations Plus Announces Further Success in Malaria Drug Design Project
Apr 11, 8:00AM Business Wire
Apr 11, 8:00AM Business Wire
Simulations Plus Reports Second Quarter and First Six Months FY2012 Financial Results
Apr 10, 8:00AM Business Wire
Apr 10, 8:00AM Business Wire
Simulations Plus Sets Date for 2nd Quarter 2012 Earnings Release and Conference Call
Apr 09, 8:00AM Business Wire
Apr 09, 8:00AM Business Wire
http://stks.co/2vDy RT @Fibline $SLP http://stks.co/2vDz Volume indicates something's going on here. Popped the Box. Worth a taste, it...
about 75 days ago by WallStreetBean
about 75 days ago by WallStreetBean
$SLP http://stks.co/2vDS Volume indicates something is going on here. Popped the Box. Worth a taste, it reamis above the Box.
about 75 days ago by Fibline
about 75 days ago by Fibline
Simulations Plus Announces Preliminary Success in Malaria Drug Design Project
Mar 15, 8:02AM Benzinga
Mar 15, 8:02AM Benzinga
Simulations Plus Promotes John DiBella to Vice President of Marketing and Sales
Mar 06, 8:00AM Business Wire
Mar 06, 8:00AM Business Wire
Simulations Plus Reports Record Second Quarter FY2012 Preliminary Revenues
Mar 05, 8:00AM Business Wire
Mar 05, 8:00AM Business Wire
It' s great to see a company recognize the value of returning money to shareholders rather than doing buybacks. Great call $SLP mgmt.
about 109 days ago by bradloncar
about 109 days ago by bradloncar
Simulations Plus Initiates Dividend, Yields 6.3%: http://stks.co/2NA6 $SLP
about 110 days ago by DynamicDividend
about 110 days ago by DynamicDividend
Simulations Plus, Inc. (SLP) Declares Ongoing $0.05 Quarterly Dividend; 6.3% Yield
Feb 13, 8:05AM Street Insider
Feb 13, 8:05AM Street Insider
Simulations Plus announces 5c cash dividend, to be distributed March 1
Feb 13, 8:03AM theflyonthewall.com
Feb 13, 8:03AM theflyonthewall.com
Simulations Plus, Inc. (SLP) Reports Q1 Earnings of $0.05, Sales Rose 9.6% Y/Y
Jan 18, 8:06AM Street Insider
Jan 18, 8:06AM Street Insider
Simulations Plus Sets Date for 1st Quarter 2012 Earnings Release and Conference Call
Jan 17, 8:00AM Business Wire
Jan 17, 8:00AM Business Wire
$SLP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/1iaD
about 155 days ago by MarketBrief
about 155 days ago by MarketBrief
Simulations Plus to Present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference
Dec 22, 8:00AM Business Wire
Dec 22, 8:00AM Business Wire
Simulations Plus Reports Preliminary Revenues for First Fiscal Quarter FY2012
Dec 06, 8:00AM Business Wire
Dec 06, 8:00AM Business Wire
Simulations Plus Reports FY2011 and Fourth Quarter FY2011 Financial Results
Nov 29, 8:00AM Business Wire
Nov 29, 8:00AM Business Wire
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2011 Earnings Release and Conference Call
Nov 22, 8:00AM Business Wire
Nov 22, 8:00AM Business Wire
Simulations Plus Signs Stock Purchase Agreement for Sale of Words+ Subsidiary
Nov 15, 1:15PM Benzinga
Nov 15, 1:15PM Benzinga
$SLP "completed the molecule design phase of its malaria NCE (new chemical entity) project..." http://stks.co/CBy WSB #25 (no pos)
about 262 days ago by wallstreetbean
about 262 days ago by wallstreetbean
$SLP "Record Quarterly Revenue of $3.44mil. Consolidated Earnings Up 42% and EPS Up 49% from 3QFY10" http://stk.ly/p9kdat WSB #28 (no pos)
about 323 days ago by wallstreetbean
about 323 days ago by wallstreetbean
$SLP reports Wed. Small-cap pharma software. WSB #28 (no position)
about 326 days ago by wallstreetbean
about 326 days ago by wallstreetbean
$SLP "Reports Preliminary Revenues for Third Fiscal Quarter of FY2011" WSB #25 (no pos) http://stk.ly/jvcWua
about 365 days ago by wallstreetbean
about 365 days ago by wallstreetbean
$SLP "Consolidated revenues up 13.5% to record $3.35mil from $2.95mil" http://stk.ly/fuGtT3 WSB #39
about 414 days ago by wallstreetbean
about 414 days ago by wallstreetbean
Weekly trend lines still positive for $SLP - - - Entry Zone for coming wk is 2.94 / 3.09
about 438 days ago by HottingerEZone
about 438 days ago by HottingerEZone
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SLP | 3.94 | -0.02 | -0.51% | 61.82M |
| SLM | 13.68 | -0.29 | -2.08% | 7.115B |
| SLI | 13.25 | -0.09 | -0.67% | 60.96M |
| SLH | 42.79 | -1.61 | -3.63% | 3.110B |
| SIVB | 55.55 | -4.11 | -6.89% | 2.613B |
| SIRI | 1.85 | -0.04 | -2.12% | 7.097B |
| SINO | 2.580 | +0.03 | +1.17% | 7.482M |
| SINA | 50.97 | -2.30 | -4.32% | 3.511B |
| SIMO | 13.16 | -0.38 | -2.81% | 449.80M |
| SIMG | 4.25 | -0.17 | -3.85% | 367.17M |
